Expedite Healing
The Magneheal is designed to expedite healing by stimulating bone and tissue growth.
Pulse Electromagnetic Field (PEMF) Therapy
Pulse Electromagnetic Field therapy, PEMF, is based on electro-magnetic pulses being applied to the body to support the healing of both soft tissue and bones. Decades of research has proven this therapy to be effective in speeding up the healing process.
The Magneheal is essentially a PEMF device that is based on clinical research, and is intended to be complimentary to the Lymwave, which stimulates the body’s lymphatic system. However, the PEMF Magneheal is more portable, simpler in its application and doesn’t necessarily require ‘specific/knowledgeable’ clinician intervention. This will allow this Magneheal treatment to be applied in the field.
Magneheal R&D and Launch
Research and Development (R&D) efforts on the Magneheal started in late 2016, with the intent of having a prototype ready for testing in May 2017. At which point we will proceed with testing its efficacy, functionality, and design.
A soft launch of the ‘Magneheal’ is planned for late 2017, and it’s expected that we will continue to do testing and fine tuning of the device. As in the case of the Harmonizer and the Lymwave, the production of the Magneheal will be done locally.
Emerging Success of PEMF Devices
Over the last few decades PEMF devices like the Magneheal have been approved by government health departments, including the FDA, for expediting healing. Over the past millennia PEMF therapy has shown to be particularly effective in improving tissue drainage, encouraging blood vessel formation to help bones knit, and reducing inflammation/Edema.
PEMF devices date back at least a hundred years. It’s a traditional tool that was driven into obscurity by the same pressures that wiped out ‘electromedical’ tools after 1935. After World War II, Japan began generating various electromagnetic wave shapes by changing electrical currents. This modality quickly moved to Europe, first in Romania and the former Soviet Union.
The modern clinical application of electro-biology in North America began in 1971 when Friedenberg described their success in the healing of a non-union fractures. Dr. Andrew Bassett at Columbia University Medical Center introduced a new approach for the treatment of non-healing bone fractures and pseudarthroses that employed very specific, biphasic low frequency electromagnetic signals.
Public awareness also increased in the mid-1970s amidst reports of successful recovery, and the enhancement of the speed and endurance of racehorses treated with electromagnetic pulse therapy.
For more information, go to www.magneheal.com
FDA Approval
Based on the published work of Dr. Bassett, in 1979 the FDA allowed electromagnetic fields to be used in the USA for non-union and delayed union fractures. A decade later the FDA allowed the use of pulsed radio frequency electromagnetic fields for the treatment of pain and edema in superficial soft tissues. It is now commonly accepted that weak electromagnetic fields are capable of initiating various beneficial biological processes including healing for delayed fractures, pain relief, and modulation of muscle tone and spasm.